December we’ve been present at three important events in the USA, Belgium and Türkiye. Furthermore, although we already started started preparations throughout 2023, we’ve now officially started our EWMA 2024 London project. ​

​

• Innovations in Wound Healing Conference – Key Largo, Florida, USA.​

We were honoured to have Dr Gregory Schultz sharing his experience on Diabetic Foot Ulcer treatment with DEBRICHEM® at the Innovations in Wound Healing Conference in Key Largo, Florida in December. ​

​

The focus of the event was on the scientific aspects of wound care innovations rather than sales. Our presence was crucial for introducing our product to local specialists and scientists, allowing us to gather valuable insights into the landscape of wound care in the USA.​

Dr. Gregory Schultz presenting at IWH​​

​

Poster with DEBRICHEM case studies at IWH​

• To clean or Debride – Antwerp, Belgium. ​

On the occasion of the ‘To Clean or Debride’ Conference held in Antwerp, Hans-Pieter Snels, presented DEBRICHEM® to a great audience of wound care nurses.​

​

In addition to the presentation, we set up a small booth where visitors could gather more information about our product. Given that we are initiating collaborations with a local partner in Belgium and have been in contact with numerous local clinicians in recent years, this event marked a significant milestone in our market introduction.​

​

• Wound Talks II: Infection and Biofilm – Ankara, Türkiye. ​

n collaboration with our distribution partner Ditanova, DEBx Medical was present during the Wound Talks II in Ankara. ​

​

The theme of this exclusive event was Infection and Biofilm. Ditanova invited 40 Wound Care Doctors from all over the country for an insightful day featuring two key speakers: Dr H. Erhan Güven and Bert Quint, who respectively discussed Diabetic Foot Ulcers emergencies and innovation in wound care with DEBRICHEM®. ​

Dr. Guven presenting

Bert Quint Presenting

Dr. Guven, the DEBx Team and Ditanova